eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Conditions: Depression; Major Depressive Disorder; Dysthymic Disorder; Depressive Symptoms; Type 2 Diabetes; PreDiabetes; Insulin Resistance
Interventions: Behavioral: Good Days Ahead (GDA); Behavioral: Problem Solving Treatment in Primary Care (PST-PC); Drug: Antidepressant Medications; Other: Active Control
Sponsors: Indiana University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 3, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments